org placeholder image

Karen Isobe

Nonclinical Study Coordinator at DURECT Corporation

  • LinkedIn

Email Email: k****@durect.com

phone noPhone Number: (***)-***-****

map
DURECT CORPORATION

DURECT CORPORATION

  • description Description
    DURECT is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-thr...

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 10 Million to 25 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

DURECT Corporation Org Chart and Mapping

Employees

Shesh Verma

Associate Director of Contracts

Julia Li

Executive Director of Finance and Assistant Controller

Linval Depass

Executive Director, Nonclinical Safety, and Principal Scientist

Crystal Susa

Manager, Intellectual Property Support

Jill Burns

Director/Senior/Exec Director, Regulatory Affairs

Frequently Asked Questions Regarding Karen Isobe

Answer: Karen Isobe works for DURECT Corporation as Nonclinical Study Coordinator

Answer: Karen Isobe’s role in DURECT Corporation is Nonclinical Study Coordinator

Answer: Karen Isobe's email address is k***@gmail.com

Answer: Karen Isobe's business email address is k****@durect.com

Answer: Karen Isobe’s direct phone number is (***)-***-****

Answer: Karen Isobe works in the industry of: Pharmaceuticals

Answer: Karen Isobe works DURECT Corporation located at Bubb Rd, Cupertino, , 95014, California, 10260, United States

Answer: DURECT Corporation's Nonclinical Study Coordinator is Karen Isobe

Answer: Karen Isobe contact details:

  • Phone number  :  (***)-***-****
  • Email  :  k****@durect.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access